← Open Payments lookup

WILLIAM EDGELL: Open Payments

NPI 1356019319 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,527 in 69 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,479 · 2025 $1,527

Food & beverage: $1,467Education: $60
CompanyPaymentsAmount
ABBVIE INC.12$314
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$197
AstraZeneca Pharmaceuticals LP8$172
Astellas Pharma US Inc6$145
Exact Sciences Corporation4$88
Aimmune Therapeutics, Inc.4$88
Sumitomo Pharma America, Inc.3$76
Phathom Pharmaceuticals, Inc.3$71
Otsuka America Pharmaceutical, Inc.4$68
Lilly USA, LLC3$56

Products named: CAPLYTA, QULIPTA, UBRELVY, AIRSUPRA, The Cologuard Plus Collection Kit, ZENPEP, Veozah, GEMTESA.

Industry payments across OR — which companies pay providers there.